Medical Use and Misuse of Prescription Opioids in US 12th-Grade Youth: School-Level Correlates.
Adolescent
Analgesics, Opioid
/ therapeutic use
Confidence Intervals
Female
Humans
Male
Marijuana Abuse
/ epidemiology
Odds Ratio
Opioid-Related Disorders
/ epidemiology
Prescription Drug Misuse
/ statistics & numerical data
Prevalence
Schools
/ statistics & numerical data
Sex Factors
Students
/ statistics & numerical data
United States
/ epidemiology
White People
/ statistics & numerical data
Journal
Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
accepted:
14
07
2020
pubmed:
12
9
2020
medline:
21
10
2020
entrez:
11
9
2020
Statut:
ppublish
Résumé
Opioid misuse and overdose remains a leading US public health concern, and many youth are first exposed to opioids via medical use. In this study, we examine school-level prevalence and correlates of medical use and misuse of prescription opioids among US 12th-grade students. A sample of 228 507 US 12th-graders in 1079 public and private schools from 2002 to 2017 from the Monitoring the Future study was used to identify school-level prevalence and correlates associated with medical use and misuse of prescription opioids. The past-year prevalence of prescription opioid misuse was 7.6% and ranged from 0% to 73% across US high schools. Lifetime medical use of prescription opioids was 16.9% and ranged from 0% to 85% across US high schools. The odds of prescription opioid misuse were higher at schools with higher proportions of male students, more white students, higher rates of marijuana use, and more medical use of prescription opioids. Students attending schools with the highest rates of medical use of prescription opioids had 57% increased odds of past-year prescription opioid misuse compared with schools with no medical use (adjusted odds ratio = 1.57, 95% confidence interval = 1.35-1.83); this association was found to weaken in recent years. Differences exist in the prevalence of prescription opioid misuse among US high schools. The association between greater school-level medical use of prescription opioids and higher prevalence of prescription opioid misuse, although declining, indicates a key risk factor to target for prevention efforts.
Sections du résumé
BACKGROUND AND OBJECTIVES
Opioid misuse and overdose remains a leading US public health concern, and many youth are first exposed to opioids via medical use. In this study, we examine school-level prevalence and correlates of medical use and misuse of prescription opioids among US 12th-grade students.
METHODS
A sample of 228 507 US 12th-graders in 1079 public and private schools from 2002 to 2017 from the Monitoring the Future study was used to identify school-level prevalence and correlates associated with medical use and misuse of prescription opioids.
RESULTS
The past-year prevalence of prescription opioid misuse was 7.6% and ranged from 0% to 73% across US high schools. Lifetime medical use of prescription opioids was 16.9% and ranged from 0% to 85% across US high schools. The odds of prescription opioid misuse were higher at schools with higher proportions of male students, more white students, higher rates of marijuana use, and more medical use of prescription opioids. Students attending schools with the highest rates of medical use of prescription opioids had 57% increased odds of past-year prescription opioid misuse compared with schools with no medical use (adjusted odds ratio = 1.57, 95% confidence interval = 1.35-1.83); this association was found to weaken in recent years.
CONCLUSIONS
Differences exist in the prevalence of prescription opioid misuse among US high schools. The association between greater school-level medical use of prescription opioids and higher prevalence of prescription opioid misuse, although declining, indicates a key risk factor to target for prevention efforts.
Identifiants
pubmed: 32913134
pii: peds.2020-0387
doi: 10.1542/peds.2020-0387
pmc: PMC7546090
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDA NIH HHS
ID : R01 DA001411
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016575
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA031160
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA036541
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA043691
Pays : United States
Informations de copyright
Copyright © 2020 by the American Academy of Pediatrics.
Déclaration de conflit d'intérêts
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Références
Addiction. 2007 Mar;102(3):455-65
pubmed: 17298654
Prev Sci. 2006 Dec;7(4):409-20
pubmed: 16900406
Am J Public Health. 2018 Apr;108(4):500-502
pubmed: 29513577
Prev Sci. 2002 Jun;3(2):105-24
pubmed: 12088136
Am J Community Psychol. 2009 Mar;43(1-2):85-97
pubmed: 19156512
Pain Physician. 2010 Sep-Oct;13(5):401-35
pubmed: 20859312
N Engl J Med. 2016 Jan 14;374(2):154-63
pubmed: 26760086
N Engl J Med. 2015 Jan 15;372(3):241-8
pubmed: 25587948
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
Subst Use Misuse. 2015;50(12):1518-28
pubmed: 26584423
Pain. 2016 Oct;157(10):2173-8
pubmed: 27227693
J Adolesc Health. 2013 Apr;52(4):480-5
pubmed: 23298996
J Am Acad Child Adolesc Psychiatry. 2019 Jul;58(7):681-691
pubmed: 30926573
Addict Behav. 2019 Mar;90:285-293
pubmed: 30472537
Addict Behav. 2005 Aug;30(7):1342-50
pubmed: 16022931
Addict Behav. 2007 Mar;32(3):562-75
pubmed: 16843611
Pediatrics. 2017 Apr;139(4):
pubmed: 28320868
JAMA. 2015 Oct 13;314(14):1468-78
pubmed: 26461997
J Psychoactive Drugs. 2003 Jul-Sep;35(3):301-9
pubmed: 14621128